News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

OncoTherapy Science, Inc. To Start Clinical Trials Of OTS102 Angiogenesis Inhibitor



10/19/2005 5:13:15 PM

Tokyo (JCNN) - OncoTherapy Science announced on April 4 that the company has decided to start clinical trials of OTS102, an angeiogensis inhibitor for cancer treatment. The company plans to begin a Phase I clinical trial within fiscal 2005.

Read at JCN Newswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES